ATHA vs CAH · $26.6M cap vs P/E 35, rev $254.25B
Athira Pharma Inc (ATHA) versus Cardinal Health Inc (CAH) — a side-by-side from cached financials, not a winner call.
Athira Pharma Inc (ATHA) is a biotechnology company listed on US.
Cardinal Health Inc (CAH) is a medical distribution company listed on NYSE.
ATHA does not have a complete income-statement cache yet.
Latest reported CAH revenue for 2026-06-30 was $254.25B. Net income was $1.71B. Revenue was up 14.2% from 2025-06-30 to 2026-06-30. CAH currently screens at market cap $53.00B and trailing P/E 34.6.
ATHA currently screens at market cap $26.6M. CAH currently screens at market cap $53.00B and trailing P/E 34.6.
Not investment advice. Open the ATHA and CAH stock pages for the full models.
Not investment advice.